<DOC>
	<DOCNO>NCT00389493</DOCNO>
	<brief_summary>This study compare short- long-term effectiveness two common therapy improve serotonin reuptake inhibitor treatment people obsessive-compulsive disorder .</brief_summary>
	<brief_title>Risperidone Cognitive-Behavioral Therapy Improving Medication Treatment Obsessive-compulsive Disorder</brief_title>
	<detailed_description>Obsessive-compulsive disorder ( OCD ) common psychiatric illness . People OCD experience unwelcome thought , know obsession , feel compel perform repetitive behavior , compulsion . Impairment due OCD symptom range mild severe , sometimes disable . The medication proven effective OCD serotonin reuptake inhibitor ( SRIs ) , even SRI treatment , patient continue experience significant OCD symptom , impaired functioning , diminish quality life . Cognitive-behavioral therapy ( CBT ) , talk therapy focus alter person 's thought behavior , medication risperidone commonly use augment SRI treatment OCD . This study compare short- long-term effectiveness exposure ritual prevention ( EX/RP ) , type CBT , risperidone augment SRI treatment people OCD . Participants double-blind study randomly assign receive EX/RP , risperidone , placebo conjunction regular SRI medication . All participant remain regular SRI stable dose . During first 2 month study , participant assign EX/RP attend therapy session twice per week . In EX/RP , participant expose feared object idea , encourage carry compulsive response . Participants assign risperidone placebo meet psychiatrist every 1 2 week . At end 8 week , participant ' OCD symptom severity assess . During time , participant respond treatment continue receive treatment additional 24 week . Participants assign EX/RP meet therapist 15 time total , participant receive risperidone placebo meet psychiatrist every 4 week . Outcomes reassess study completion . Ortho McNeil Janssen Scientific Affairs , LLC provide medication placebo study . For information relate study , please follow link : http : //clinicaltrials.gov/show/NCT00045903</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Primary diagnosis OCD Currently stable adequate dose SRI Sufficient severity symptom warrant additional augmentation treatment Medical psychiatric condition would make participation study unsafe Currently receive psychotherapy elsewhere time study entry Previously ( within 12 week prior study entry ) attend 8 session EX/RP within 2month period receive least 4 week antipsychotic augmentation adequate SRI dose Currently treat SRI first time yet respond , try another SRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>OCD</keyword>
	<keyword>Augmentation</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Cognitive-Behavioral Therapy</keyword>
</DOC>